This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
August 01, 2012 4:30 pm ET
Joe E. Kiani - Founder, Chairman and Chief Executive Officer
Mark P. de Raad - Chief Financial Officer, Principal Accounting Officer, Executive Vice President and Corporate Secretary
William R. Quirk - Piper Jaffray Companies, Research Division
Joanne K. Wuensch - BMO Capital Markets U.S.
Matthew Dolan - Roth Capital Partners, LLC, Research Division
Brian Weinstein - William Blair & Company L.L.C., Research Division
John M. Putnam - Capstone Investments, Research Division
Lennox Ketner - BofA Merrill Lynch, Research Division
Ben C. Haynor - Feltl and Company, Inc., Research Division
Mary Nielson - ThinkEquity LLC, Research Division
Good afternoon, ladies and gentlemen, and welcome to Masimo's Second Quarter 2012 Earnings Conference Call. This company's press release is available at www.masimo.com. [Operator Instructions] I am pleased to introduce Sheree Aronson, Masimo's Vice President of Investor Relations. Please go ahead.
Hello, everyone. Joining me today are Chairman and CEO, Joe Kiani; and Executive Vice President of Finance and CFO, Mark de Raad. This call will contain forward-looking statements, which reflect Masimo's best current judgment. However, they are subject to risks and uncertainties that could cause actual results to differ materially. Risk factors that could cause our actual results to differ materially from our projections and forecasts are discussed in detail in our SEC filings, including our most recent Form 10-Q. You will find these in the Investors section of our website.
I also want to remind you that we are hosting our first-ever Masimo Investor Day on the morning of September 20 at The Pierre Hotel in New York. We hope you will plan to join us for this event, which will provide an in-depth review of Masimo's strategy, technology and growth opportunities, and include executive presentations, clinical panel discussions and product demonstrations.